Pathos

Pathos

Biotechnology Research

Chicago, Illinois 3,290 followers

Re-engineering drug development and leveraging the power of advanced AI technologies

About us

Pathos was borne from the belief that cancer is a collection of hundreds of rare diseases and can be best described by pathways accounting for the pathophysiology of patients. We license or co-develop clinical-stage therapeutics to ensure highly efficacious drugs are developed for the patients most likely to benefit and with significant unmet needs. Our patient selection strategies are optimized for the fastest path to approval to improve patient outcomes as quickly as possible. Our aim is ultimately to accelerate the translation of real-world data into breakthrough therapies for patients that need them most.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Chicago, Illinois
Type
Privately Held
Founded
2022
Specialties
AI, Biotechnology, Drug Development, Oncology, Precision Medicine, Cancer Biology, Data Science, Machine Learning, Clinical Trials, Drug Discovery, Precision Oncology, Biopharma, Pharma, and Computational Biology

Locations

Employees at Pathos

Updates

Similar pages

Funding